Latest IVDR extension: What does it mean for you?
Available on demand

Despite considerable progress in transitioning to the IVD rules introduced in 2017, and the additional time given to implement them, progress in the sector remains slow. Last year, the European Commission took steps to ensure the availability of medical devices, and now in 2024 further steps are being proposed to ensure the availability of certain IVDs, accelerating the sector’s progress towards the transition.This webinar brings together experts from notified bodies, industry, and the legal sector to deliver a comprehensive update on what this latest extension to the IVDR means for you.

Join this experienced panel of speakers to:

  • Understand the details of the latest proposal, the gradual roll-out of EUDAMED and which IVDs are impacted
  • Find out about the impact on the conformity assessment process
  • Receive advice on what to consider first, given this extra time and what you need to share with senior managers as you navigate the transition
  • Listen to them share their views on what could be on the horizon
  • Participate in a live Q&A with our experts and benefit from accessing their unique perspectives and knowledge

Who should attend?

  • IVD Decision-makers/ market strategy
  • R&D / Clinical Performance Study staff
  • Quality and regulatory staff
  • Operational staff
  • EU Authorised Representatives and importers of IVDs

Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

LGC Biosearch Technologies